These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 506658)
1. [The effect of aldosterone antagonists in juvenile heart surgery]. Wimmer M; Parth K; Holzer H Acta Med Austriaca; 1979; 6(1):8-12. PubMed ID: 506658 [TBL] [Abstract][Full Text] [Related]
2. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists. Haschke F; Wimmer M; Parth K Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888 [TBL] [Abstract][Full Text] [Related]
3. [Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone]. Gleichmann U; Bostroem B; Kreuzer H; Löhr B Anaesthesist; 1965 Dec; 14(12):355-9. PubMed ID: 5870012 [No Abstract] [Full Text] [Related]
4. [Studies on the effect of the aldosterone-antagonist aldadeine-potassium on secondary aldosteronism after surgery with the heart-lung machine]. Gleichmann U; Bircks W; Bostroem B; Kreuzer H Arzneimittelforschung; 1967 Jun; 17(6):741-4. PubMed ID: 5632376 [No Abstract] [Full Text] [Related]
5. [Experiences with aldactone in pediatric cardiology (author's transl)]. Wimmer M; Bachl G; Schlemmer M; Stiskal A Padiatr Padol; 1979; 14(4):363-72. PubMed ID: 530724 [TBL] [Abstract][Full Text] [Related]
6. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Koch A; Kitzsteiner T; Zink S; Cesnjevar R; Singer H Int J Cardiol; 2007 Jan; 114(3):339-44. PubMed ID: 16753233 [TBL] [Abstract][Full Text] [Related]
7. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. Gessler P; Knirsch W; Schmitt B; Rousson V; von Eckardstein A J Pediatr; 2006 Mar; 148(3):372-6. PubMed ID: 16615970 [TBL] [Abstract][Full Text] [Related]
9. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
10. Hyperaldosteronism after heart surgery in children. Part II: Regulation of aldosterone secretion. Haschke F; Wimmer M; Parth K Padiatr Padol; 1981; 16(3):327-33. PubMed ID: 7019824 [TBL] [Abstract][Full Text] [Related]
11. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Alvarez Kindelan A; Pérez Navero JL; Ibarra de la Rosa I; Concha Ruiz M; Montilla López P; Romanos Lezcano A Crit Care Med; 1994 Nov; 22(11):1754-61. PubMed ID: 7956278 [TBL] [Abstract][Full Text] [Related]
12. [Aldosterone and aldosterone antagonists in surgery]. Oelert H Anaesthesist; 1971 Jun; 20(6):205-11. PubMed ID: 4943021 [No Abstract] [Full Text] [Related]
13. [Use of a new water-soluble aldosterone-antagonist in surgery. Early clinical results]. Nahum M; Ratto GB; Motta G Minerva Med; 1976 Apr; 67(19):1263-75. PubMed ID: 934482 [TBL] [Abstract][Full Text] [Related]
14. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome. Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780 [No Abstract] [Full Text] [Related]
15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [TBL] [Abstract][Full Text] [Related]
16. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy. Wisgerhof M J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794 [TBL] [Abstract][Full Text] [Related]
17. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension]. Skrabal F; Mauser R Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of secondary hyperaldosteronism]. Werning C; Siegenthaler W Dtsch Med Wochenschr; 1969 Oct; 94(40):2051-3. PubMed ID: 5356332 [No Abstract] [Full Text] [Related]
19. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone. Grattan MJ; McCrindle BW Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. Komai H; Adatia IT; Elliott MJ; de Leval MR; Haworth SG J Thorac Cardiovasc Surg; 1993 Sep; 106(3):473-8. PubMed ID: 8361190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]